admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)...

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study...

PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork...

Psychedelic Bulletin: Mindstate Design Labs Leaves Stealth Mode; No Synthetic Psilocybin...

Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights

1...157158159...218 Page 158 of 218

Pα+ Psychedelic Bulletin #197: Portuguese Health-Related Professions Unite on Psychedelics; Shrooms,...

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin